These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25363430)

  • 21. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health impact and economic analysis of NGO-supported neurosurgery in Bolivia.
    Ament JD; Greene KR; Flores I; Capobianco F; Salas G; Uriona MI; Weaver JP; Moser R
    J Neurosurg Spine; 2014 Apr; 20(4):436-42. PubMed ID: 24527825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes measurement: health state preferences and economic evaluation.
    Oldridge NB
    Assist Technol; 1996; 8(2):94-102. PubMed ID: 10163933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation.
    Goeree R; Hopkins R; Marshall JK; Armstrong D; Ungar WJ; Goldsmith C; Allen C; Anvari M
    Value Health; 2011; 14(2):263-73. PubMed ID: 21402295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health economic evaluations help inform payers of the best use of scarce health care resources.
    O'Reilly D; Gaebel K; Xie F; Tarride JE; Goeree R
    Int J Circumpolar Health; 2011 Sep; 70(4):417-27. PubMed ID: 21924008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions.
    Tonin FS; Aznar-Lou I; Pontinha VM; Pontarolo R; Fernandez-Llimos F
    Pharm Pract (Granada); 2021; 19(1):2302. PubMed ID: 33727994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries.
    Franken M; Heintz E; Gerber-Grote A; Raftery J
    Value Health; 2016 Dec; 19(8):951-956. PubMed ID: 27987645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complex interface between economy and healthcare: An introductory overview for clinicians.
    Ottolini FL; Buggio L; Somigliana E; Vercellini P
    Eur J Intern Med; 2016 Dec; 36():1-6. PubMed ID: 27577606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of economic evaluation on quality management in spine surgery.
    Boos N
    Eur Spine J; 2009 Aug; 18 Suppl 3(Suppl 3):338-47. PubMed ID: 19337760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valuing the Clinical Effectiveness of Therapeutics.
    Listl S; Faggion CM
    J Evid Based Dent Pract; 2016 Jun; 16(2):86-9. PubMed ID: 27449834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Health economics studies in dermatology].
    Rogalski C; Simon J; Paasch U
    Hautarzt; 2006 Apr; 57(4):297-302. PubMed ID: 15971088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future costs in cost effectiveness analysis.
    Lee RH
    J Health Econ; 2008 Jul; 27(4):809-818. PubMed ID: 18201785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basic principles and methodological considerations of health economic evaluations].
    Loza C; Castillo-Portilla M; Rojas JL; Huayanay L
    Rev Peru Med Exp Salud Publica; 2011; 28(3):518-27. PubMed ID: 22086635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measures of efficiency in healthcare: QALMs about QALYs?
    Schlander M
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(3):214-26. PubMed ID: 20608250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical economics review: gastroenterology.
    Bodger K; Daly MJ; Heatley RV; Williams DR
    Aliment Pharmacol Ther; 1996 Feb; 10(1):55-60. PubMed ID: 8871444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness in surgery: concepts of cost-utility analysis explained.
    Vissapragada R; Bulamu N; Karnon J; Yazbek R; Watson DI
    ANZ J Surg; 2021 Sep; 91(9):1717-1723. PubMed ID: 33480173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review.
    Cacciatore P; Visser LA; Buyukkaramikli N; van der Ploeg CPB; van den Akker-van Marle ME
    Int J Neonatal Screen; 2020 Nov; 6(4):. PubMed ID: 33238605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality Assessment of Reporting of Economic Evaluation in Cardiac Sugery: Has it Improved?
    Guerre P; Laaboub N; Colin C; Obadia JF; Julien C; Hrifach A; Rabier H; Serrier H; Grinberg D
    Int J Technol Assess Health Care; 2019 Jan; 35(1):45-49. PubMed ID: 30744730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluations and their use in infection prevention and control: a narrative review.
    Rennert-May E; Conly J; Leal J; Smith S; Manns B
    Antimicrob Resist Infect Control; 2018; 7():31. PubMed ID: 29492261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.